Not applicableUnknownNCT06151691
What this trial is testing
Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach
Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 51
Showing 20 of 0 results